CASE STUDY
Creating a liquid biopsy application for multi-cancer analysis at Centre Léon Bérard
See how Centre Léon Bérard scaled their cell-free DNA analysis with a tailor-made liquid biopsy solution for mutation detection across cancer types.
Discover how Centre Léon Bérard (CLB) and SOPHiA GENETICS co-developed a 21-gene liquid biopsy solution for multi-cancer analysis, designed to accurately detect both guideline-recommended and emerging biomarkers. Explore the full story to learn how this targeted approach has streamlined CLB’s analysis workflows, enabling the sequencing of 600 cell-free DNA samples per year with significantly faster turnaround times compared to traditional tissue-based methods.